Search

everythinglearnresearchcommunity

for

Search:↓

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Finasteride doesn't harm bone density in older men with BPH.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Physical activity, height, and smoking affect prostate cancer risk.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Certain natural compounds called terpenes may help prevent prostate cancer.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.